| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/03/1992 | WO1992014460A1 Use of lacidipine for the treatment of arteriosclerosis |
| 09/03/1992 | WO1992014458A1 Benzopyran phenol derivates for use as antibacterial, antiviral or immunostimulating agents |
| 09/03/1992 | WO1992014457A1 Novel therapeutic use of pycnometols for the preparation of anti_inflammatory medicaments |
| 09/03/1992 | WO1992014456A1 Use of pharmaceutical compounds in the treatment of symptoms of disorders related to neurological diseases and etiologically related symptomology |
| 09/03/1992 | WO1992014455A1 METHOD FOR CONTROLLING ABNORMAL CONCENTRATION TNF α IN HUMAN TISSUES |
| 09/03/1992 | WO1992014453A1 Compositions and methods of treatment of sympathetically maintained pain |
| 09/03/1992 | WO1992014450A1 Sustained release drug delivery devices |
| 09/03/1992 | WO1992014445A1 Sustained drug release through topical application of bioadhesive liposomes |
| 09/03/1992 | WO1992014444A1 Formulations for delivery of drugs by metered dose inhalers with reduced or no chlorofluorocarbon content |
| 09/03/1992 | WO1992014442A1 Composition for use in transdermal administration |
| 09/03/1992 | WO1992012715A3 The use of loperamide and related compounds for treatment of respiratory disease symptoms |
| 09/03/1992 | WO1992011850A3 Use of calpain inhibitors in the inhibition and treatment of neurodegeneration |
| 09/03/1992 | DE4106283A1 New and known tri-cyclic iso-indolinone derivs. used as antiviral agents - for prophylaxis and treatment of HIV, ARC, AIDS, HTLV, herpes simplex, papilloma, varicella zoster, etc. |
| 09/03/1992 | CA2105179A1 3-piperidinylmethylcarboxylate substituted indoles |
| 09/03/1992 | CA2104677A1 Compositions for topical administration containing fluticasone propionate and oxiconazole or its salts |
| 09/03/1992 | CA2103568A1 Method of treating systemic lupus erythematosus |
| 09/03/1992 | CA2101933A1 Neuroprotectant agents |
| 09/03/1992 | CA2081112A1 Thiazolidine-2,4-dione derivative, salt thereof, and production thereof |
| 09/02/1992 | WO1992015585A1 1-azabicyclo[3.2.2]nonan-3-amine derivatives |
| 09/02/1992 | WO1992015578A1 Triheteroarylmethanes, method for preparing them, pharmaceutical preparations containing them and their use to manufacture drugs |
| 09/02/1992 | WO1992015303A1 Treatment of cognitive disorders |
| 09/02/1992 | WO1992015302A1 Treatment of addiction to drugs and substances of abuse |
| 09/02/1992 | WO1992015296A1 Remedy for renal diseases |
| 09/02/1992 | WO1992015276A2 Therapeutic and cosmetic compositions for treatment of skin |
| 09/02/1992 | EP0501892A1 Diazotized heterocyclic derivatives N-substituted by a biphenylmethyl group, their preparation and pharmaceutical compositions containing them |
| 09/02/1992 | EP0501889A2 Anti-epileptic composition containing striripentol associated with an anti-epileptic drug |
| 09/02/1992 | EP0501870A1 New pharmaceutical compositions, particularly for the treatment of functional infections of the large intestines, and process for obtaining them |
| 09/02/1992 | EP0501763A1 Taste-masked buflomedil preparation |
| 09/02/1992 | EP0501713A1 Optically active aminoketone derivative and method for preparing same |
| 09/02/1992 | EP0501705A1 Use of tomoxetine for the treatment of lower urinary tract disorders |
| 09/02/1992 | EP0501678A2 Treatment of ocular hypertension with a synergistic combination |
| 09/02/1992 | EP0501656A2 New benzene derivatives having (NGF) production-promoting activity |
| 09/02/1992 | EP0501641A1 L-2-oxothiazolidine-4-carboxylate and glutathion esters for the treatment of hepatic diseases |
| 09/02/1992 | EP0501637A2 Use of L-2-oxothiazolidine-4-carboxylate alone or in combination with glutathione esters and/or amino acids in the treatment of reperfusion injury |
| 09/02/1992 | EP0501592A1 Triheteroarylmethanes, process for their preparation, pharmaceutical compositions containing them and their use for the preparation of medicines |
| 09/02/1992 | EP0501579A1 Naphthalene lactones as inhibitors of leukotriene biosynthesis |
| 09/02/1992 | EP0501578A1 Pyranylphenyl hydroxyalkylnaphthoic acids as inhibitors of leukotriene biosynthesis |
| 09/02/1992 | EP0501568A1 Substituted cyclic sulphamide derivatives |
| 09/02/1992 | EP0501552A1 4-[(2-Benzothiazolyl)methylamino]-alpha-[(3,4-difluorophenoxy)methyl]-1-piperidineethanol |
| 09/02/1992 | EP0501442A1 8-chloro-benzothiazepine-compound for prophylaxis and treatment of sequelae of cerebral neurocyte necrosis |
| 09/02/1992 | EP0501378A1 NMDA Antagonists |
| 09/02/1992 | EP0501322A1 3-Piperidinylmethylcarboxylate substituted indoles |
| 09/02/1992 | EP0501293A1 Use of S-adenosyl-L-methionine in the treatment of intrahepatic cholestasis determined by total parenteral nutrition |
| 09/02/1992 | EP0501269A1 Imidazole and benzimidazole derivatives |
| 09/02/1992 | EP0501251A2 The enantiomer (+)-N-(2-ethoxyphenyl)-N',N'-(1,2,2-trimethylpropyl)-2-nitroethen-1,1-diamine, method for its preparation and its use |
| 09/02/1992 | EP0501250A1 Fucose-marked batracylin derivatives |
| 09/02/1992 | EP0501206A2 Phenone compounds, process for their preparation and their pharmaceutical preparations |
| 09/02/1992 | EP0501205A1 Antiphlogistic means |
| 09/02/1992 | EP0501056A1 Danazol containing compositions for the treatment of endometriosis |
| 09/02/1992 | EP0500953A1 Antineoplastic effect potentiator and antineoplastic agent |
| 09/02/1992 | EP0500905A1 Pharmaceutical compositions for use in treating aids. |
| 09/02/1992 | EP0500893A1 Preservation of blood, tissues and biological fluids |
| 09/02/1992 | EP0500864A1 Antimuscarinic bronchodilators |
| 09/02/1992 | EP0500807A1 Tissue moisturizing composition and method |
| 09/02/1992 | EP0500802A1 Liposomal compositions. |
| 09/02/1992 | EP0500776A1 Poly(alkyl and alkenyl phosphate)s and their thiophosphate and selenophosphate derivatives as antiviral agents |
| 09/02/1992 | EP0500751A1 rRNA SPECIFIC OLIGONUCLEOTIDES |
| 09/02/1992 | EP0500713A1 New derivatives of 3,3,5-trimethylcyclohexanol methyl-2 propionate, preparation method and therapeutical compositions containing them |
| 09/02/1992 | EP0500688A1 Method for inhibiting the growth of salmonella |
| 09/02/1992 | EP0500686A1 Tricyclic 6,5,5]/ 6,6,5]-fused oxazolidinone antibacterial agents. |
| 09/02/1992 | EP0500658A1 A nicotine containing stimulant unit. |
| 09/02/1992 | EP0500653A1 Inhibitors of purine nucleoside phosphorylase |
| 09/02/1992 | EP0500621A1 Cycloalkyl-substituted glutaramide diuretic agents |
| 09/02/1992 | EP0500610A1 Nucleoside derivatives |
| 09/02/1992 | EP0500586A1 Pyrimidine biosynthesis inhibitors useful as immunosuppressive agents |
| 09/02/1992 | EP0494974A4 Fluorocarbon emulsions containing amino acid based anti-inflammatory agents and buffer systems |
| 09/02/1992 | EP0401243B1 Medicinal preparations characterized by a combination of cytostatic agents, hormonal therapeutic agents and phosphone derivatives |
| 09/02/1992 | EP0395656B1 Lipophilic salts of s-adenosyl-l-methionine (sam) with acylated taurine derivatives |
| 09/02/1992 | EP0335970B1 Tablet for use in the treatment of progesterone deficiency |
| 09/02/1992 | EP0304493B1 Hydroxystyrene derivatives |
| 09/02/1992 | CN1064143A Multipurpose nozzle for gas stove (range) |
| 09/02/1992 | CN1064079A Steroids |
| 09/02/1992 | CN1064078A Steroid esters |
| 09/02/1992 | CN1064076A N-substituted quinoline derivatives, preparation process, intermediates, use and composition |
| 09/02/1992 | CN1064075A Carbamic acid derivatives and method for preparing same |
| 09/02/1992 | CA2105313A1 Therapeutic and cosmetic compositions for treatment of skin |
| 09/02/1992 | CA2105291A1 Remedy for renal diseases |
| 09/02/1992 | CA2105175A1 Triheteroarylmethanes, method for preparing them, pharmaceutical preparations containing them and their use to manufacture drugs |
| 09/01/1992 | US5144081 Sunscreen agents |
| 09/01/1992 | US5144059 Cardiovascular and kidney disorders |
| 09/01/1992 | US5144037 Viricides |
| 09/01/1992 | US5144035 Chemical intermediates for platelet activating factor antagonists |
| 09/01/1992 | US5144029 Derivatives of 1-[3-(4-hydroxyphenyl) 1-hydroxy 1-propyl] benzene substituted in position 2 by an aminoalkyleneoxy chain, the method of preparing same and the application thereof to therapeutics |
| 09/01/1992 | US5144027 Cephalosporins, process for producing the same, intermediates thereof and process for producing the intermediates |
| 09/01/1992 | US5143938 Propanamines, their pharmacological properties and their application for therapeutic in particular antidiarrheal, purposes |
| 09/01/1992 | US5143937 Treatment of hyperlipidemia |
| 09/01/1992 | US5143936 Benzopyran compound and its pharmaceutical use |
| 09/01/1992 | US5143935 Benzamide derivatives |
| 09/01/1992 | US5143934 Method and composition for controlled delivery of biologically active agents |
| 09/01/1992 | US5143928 3,5-di-tertiarybutyl-4-hydroxyphenylmethylene derivatives of 2-substituted thiazolidinones, oxazolidinones, and imidazolidinones as antiinflammatory agents |
| 09/01/1992 | US5143926 Substituted pyridine-2,4-dicarboxylic acid compounds and methods of use thereof |
| 09/01/1992 | US5143925 Alteration of rate and character of hair growth |
| 09/01/1992 | US5143924 Hypotensive agents |
| 09/01/1992 | US5143923 Psychological disorders |
| 09/01/1992 | US5143920 Substituted 4-aminoquinoline derivatives as gastric secretion inhibitors |
| 09/01/1992 | US5143916 Naphthylpiperazines useful as 5-ht1a receptor ligands |
| 09/01/1992 | US5143912 Muscle relaxants, anticonvulsants, anxiolytic agents |
| 09/01/1992 | US5143911 Bactericides |
| 09/01/1992 | US5143910 Piperaziniocephalosporins |
| 09/01/1992 | US5143909 Treating androgen-dependent disorders |